Skip to content
OpenCapital
Get started

Utah Medical Products UTMD Long-Term Debt and Finance Lease Obligations

Long-Term Debt and Finance Lease Obligations at other companies

The Cooper Companies, Inc. logo
The Cooper Companies, Inc.COO
——
Pediatrix Medical Group logo
Pediatrix Medical GroupMD
——
Medtronic logo
MedtronicMDT
——

Other financials

Income statement

See full
Revenue$8.7M-10.2%
Gross profit$5.3M-4.6%
Operating income$2.6M-18.6%
Net income$2.6M-14.4%
EPS (diluted)$0.82-10.9%

Balance sheet

See full
Cash & equivalents$87.4M+4.9%
Total debt$210.0K—
Total equity$120.4M+2.8%
Total assets$124.4M+1.5%

Cash flow

See full
Operating cash flow$3.1M-30.4%
CapEx$130.0K-29.3%
Free cash flow$3.0M-30.4%

Valuation

See full
Market cap$219.63M+26.4%
Enterprise value$132.44M+42.5%
P/E20.3×+6.4×
P/S5.9×+1.4×

Profitability

See full
Gross margin57.9%-0.4pp
Operating margin28.8%-3.9pp
Net margin28.9%-4.1pp
FCF margin34.7%0.0pp

Returns & leverage

See full
Return on equity9.1%-1.4pp
Debt / equity0×—
Current ratio28.6×+6.3×

Where this comes from

Reported directly by Utah Medical Products in its filing.

Tagged under the XBRL concept us-gaap:LongTermDebtAndCapitalLeaseObligations.

The official record: Utah Medical Products’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Utah Medical Products's long-term debt and finance lease obligations.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Utah Medical Products's long-term debt and finance lease obligations?
Utah Medical Products (UTMD) reported long-term debt and finance lease obligations of $210K in Q1 2026.
How has Utah Medical Products's long-term debt and finance lease obligations changed year-over-year?
Utah Medical Products's long-term debt and finance lease obligations decreased by 21.9% year-over-year, from $269K to $210K.
What is the long-term trend for Utah Medical Products's long-term debt and finance lease obligations?
Over 2 years (2023 to 2025), Utah Medical Products's long-term debt and finance lease obligations has grown at a -12.7% compound annual growth rate (CAGR), from $295K to $225K.